tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

JP:190A Stock Latest News

Chordia Regains Full Rights to CTX-177 After Ending Ono License Deal
Company AnnouncementsChordia Regains Full Rights to CTX-177 After Ending Ono License Deal
1d ago
190A
Chordia Therapeutics’ Major Shareholder Diluted Below 10% After Warrant Exercises
PremiumCompany Announcements
Chordia Therapeutics’ Major Shareholder Diluted Below 10% After Warrant Exercises
16d ago
190A
Chordia Therapeutics Narrows Quarterly Loss but Forecasts Continued Full-Year Red Ink
PremiumCompany Announcements
Chordia Therapeutics Narrows Quarterly Loss but Forecasts Continued Full-Year Red Ink
1M ago
190A
Chordia Therapeutics to Record Grant Income in Fiscal Year 2026
PremiumCompany Announcements
Chordia Therapeutics to Record Grant Income in Fiscal Year 2026
3M ago
190A
Chordia Therapeutics’ CTX-712 Study: A Potential Breakthrough in AML and HR-MDS Treatment
PremiumCompany Announcements
Chordia Therapeutics’ CTX-712 Study: A Potential Breakthrough in AML and HR-MDS Treatment
4M ago
190A
Chordia Therapeutics Restructures Capital to Strengthen Financial Foundation
PremiumCompany AnnouncementsChordia Therapeutics Restructures Capital to Strengthen Financial Foundation
4M ago
190A
Chordia Therapeutics Reports Fiscal Year 2025 Financial Results
Premium
Company Announcements
Chordia Therapeutics Reports Fiscal Year 2025 Financial Results
4M ago
190A
Chordia Therapeutics Reports Continued Losses in Latest Financial Results
Premium
Company Announcements
Chordia Therapeutics Reports Continued Losses in Latest Financial Results
7M ago
190A
Chordia Therapeutics Secures Grant for Cancer Therapy Research
PremiumCompany Announcements
Chordia Therapeutics Secures Grant for Cancer Therapy Research
8M ago
190A
Chordia Therapeutics Announces Change in Major Shareholder
PremiumCompany Announcements
Chordia Therapeutics Announces Change in Major Shareholder
9M ago
190A
Chordia Therapeutics Regains Rights to CTX-177 as Ono Discontinues Development
PremiumCompany Announcements
Chordia Therapeutics Regains Rights to CTX-177 as Ono Discontinues Development
10M ago
190A
Chordia Therapeutics Reports Financial Losses for Six-Month Period Ending February 2025
PremiumCompany Announcements
Chordia Therapeutics Reports Financial Losses for Six-Month Period Ending February 2025
10M ago
190A
Chordia Therapeutics Secures Orphan Drug Designation for Rogocekib in the U.S.
PremiumCompany AnnouncementsChordia Therapeutics Secures Orphan Drug Designation for Rogocekib in the U.S.
1y ago
190A
Chordia Therapeutics Unveils New Research Insights
Premium
Company Announcements
Chordia Therapeutics Unveils New Research Insights
1y ago
190A
Chordia Therapeutics Focuses on Innovative Drug Development
Premium
Company Announcements
Chordia Therapeutics Focuses on Innovative Drug Development
1y ago
190A
Chordia Therapeutics Advances Cancer Drug Development
PremiumCompany Announcements
Chordia Therapeutics Advances Cancer Drug Development
1y ago
190A
Chordia Therapeutics Enhances Transparency with Earnings Transcript
PremiumCompany Announcements
Chordia Therapeutics Enhances Transparency with Earnings Transcript
1y ago
190A
Chordia Therapeutics’ Successful CTX-712 Trial Results
PremiumCompany Announcements
Chordia Therapeutics’ Successful CTX-712 Trial Results
1y ago
190A
Chordia Therapeutics Faces Fiscal Year Losses
PremiumCompany Announcements
Chordia Therapeutics Faces Fiscal Year Losses
1y ago
190A
Chordia Therapeutics Unveils Promising Cancer Drug Trial
PremiumCompany AnnouncementsChordia Therapeutics Unveils Promising Cancer Drug Trial
1y ago
190A
Chordia Therapeutics Recognized at Japan Startup Awards
Premium
Company Announcements
Chordia Therapeutics Recognized at Japan Startup Awards
2y ago
190A
Chordia Therapeutics Posts Nine-Month Net Loss
Premium
Company Announcements
Chordia Therapeutics Posts Nine-Month Net Loss
2y ago
190A

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >